Targets the PI3K/AKT and MAPK pathways to increase antioxidant levels and decrease the levels of autophagy-related proteins; protects the hippocampal CA3 region from neuronal damage caused by epilepsy. The gene discussed is AKT1; the disease is epilepsy.